IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

RONCHETTI, DOMENICA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.969
NA - Nord America 4.964
AS - Asia 4.609
SA - Sud America 417
AF - Africa 144
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.124
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.785
DE - Germania 2.882
CN - Cina 1.511
GB - Regno Unito 1.342
SG - Singapore 1.163
IT - Italia 966
SE - Svezia 430
VN - Vietnam 427
HK - Hong Kong 400
BD - Bangladesh 371
RU - Federazione Russa 333
BR - Brasile 295
FR - Francia 288
IN - India 207
UA - Ucraina 144
NL - Olanda 141
CA - Canada 132
IE - Irlanda 119
KR - Corea 117
TR - Turchia 107
FI - Finlandia 98
ID - Indonesia 79
EU - Europa 65
JP - Giappone 59
CI - Costa d'Avorio 51
CO - Colombia 46
EG - Egitto 45
DK - Danimarca 37
PL - Polonia 32
AR - Argentina 31
CH - Svizzera 30
MX - Messico 26
SA - Arabia Saudita 24
AT - Austria 21
GR - Grecia 21
ES - Italia 20
IQ - Iraq 20
AU - Australia 18
PK - Pakistan 16
MY - Malesia 14
BE - Belgio 13
EC - Ecuador 12
TH - Thailandia 11
CZ - Repubblica Ceca 10
PH - Filippine 10
SC - Seychelles 10
ZA - Sudafrica 10
AE - Emirati Arabi Uniti 9
MA - Marocco 9
PY - Paraguay 9
AL - Albania 8
JO - Giordania 8
UZ - Uzbekistan 8
CL - Cile 7
LU - Lussemburgo 6
NP - Nepal 6
TN - Tunisia 6
VE - Venezuela 6
BH - Bahrain 5
CR - Costa Rica 5
JM - Giamaica 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
RO - Romania 5
IR - Iran 4
KZ - Kazakistan 4
TW - Taiwan 4
BG - Bulgaria 3
BO - Bolivia 3
CY - Cipro 3
GY - Guiana 3
HU - Ungheria 3
LB - Libano 3
PR - Porto Rico 3
QA - Qatar 3
TJ - Tagikistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
DZ - Algeria 2
EE - Estonia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
MD - Moldavia 2
NO - Norvegia 2
OM - Oman 2
RS - Serbia 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GM - Gambi 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 17.178
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 2.164
Southend 1.142
Singapore 626
Ashburn 566
Hong Kong 353
Milan 335
Dallas 325
Beijing 319
Chandler 293
San Jose 255
Fairfield 196
Seattle 186
Council Bluffs 177
Wilmington 161
Princeton 131
Los Angeles 130
Ho Chi Minh City 126
Woodbridge 123
Jacksonville 116
Dublin 115
Hefei 114
Santa Clara 114
Hanoi 108
New York 102
Dearborn 95
Houston 94
Ann Arbor 90
Cambridge 86
Bengaluru 79
Lauterbourg 75
Nanjing 68
Toronto 68
Moscow 67
Guangzhou 60
Phoenix 60
Jakarta 59
Shanghai 58
Boardman 56
Buffalo 55
Redmond 52
Abidjan 51
Mountain View 46
Somerville 46
Des Moines 44
Rome 43
Alexandria 40
Andover 40
São Paulo 39
Tokyo 38
Helsinki 36
Sakarya 36
Bogotá 35
Columbus 35
Serra 34
Jinan 32
Seoul 32
Shenyang 31
Zhengzhou 30
Changsha 29
Warsaw 28
Berlin 27
Nanchang 27
Pisa 27
The Dalles 27
Chicago 26
Tianjin 26
London 25
Cangzhou 23
Naples 23
Nuremberg 22
Athens 20
Jeddah 20
Munich 19
Da Nang 18
Atlanta 17
Dong Ket 17
Shenzhen 17
Boston 16
Eitensheim 16
Hangzhou 15
Hebei 15
Turin 15
Wuhan 15
Paris 14
Redwood City 14
Rochester 14
Saint Petersburg 14
Washington 14
Bodio Lomnago 13
Bühl 13
Kunming 13
Orem 13
San Diego 13
Haiphong 12
Hanover 12
Jiaxing 12
Montreal 12
Silver Spring 12
Turku 12
Bitonto 11
Totale 10.835
Salva come PNG Salva come JPEG
Nome #
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myeloma 401
Identification of specific transcriptional patterns associated with hyperdiploidy in multiple myeloma 400
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma 377
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 354
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 344
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome 337
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma 334
The expression pattern of small nucleolar and small cajal body-specific RNAS characterizes distinct molecular subtypes of multiple myeloma 330
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma 326
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 314
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 309
Long Non-Coding RNAs in Multiple Myeloma 301
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 296
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 289
NEAT1 Long Isoform Is Highly Expressed in Chronic Lymphocytic Leukemia Irrespectively of Cytogenetic Groups or Clinical Outcomek 288
The role of notch pathway in multiple myeloma progression toward IL-6 independence 278
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome 269
In silico characterization of miRNA and long non-coding RNA interplay in multiple myeloma 262
Molecular definition of 17P11-P12 amplification in multiple myeloma 261
MicroRNA genes associated with genomic alterations or gene expression modulation contribute to enhance genetic heterogeneity in Multiple Myeloma 260
Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses 258
Characterization of the t(4;14)(p16.3;q32) in the KMS-18 multiple myeloma cell line 258
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems? 258
Expression levels of NONO, a nuclear protein primarily involved in paraspeckles function, are associated with several deregulated molecular pathways and poor clinical outcome in multiple myeloma 253
Prevalence of ras gene mutations in the context of a molecular classification of multiple myeloma 250
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma 249
Deregulation of MIR-221/222 cluster affects P27 expression in multiple myeloma 243
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs 234
Long non-coding RNAs in B-cell malignancies: a comprehensive overview 233
Dissecting the biological relevance and clinical impact of lncrna miat in multiple myeloma 230
Distinct patterns of global promoter methylation in early stage chronic lymphocytic leukemia 229
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 228
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancers 228
Integrative genomic approach identifies deregulated micrornas in human myeloma cell lines 225
Small nucleolar RNAs as new biomarkers in chronic lymphocytic leukemia 225
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 221
Integrative Genomic Approach Identifies Deregulated MicroRNAs in Human Myeloma Cell Lines 221
Repetitive DNA methylation in multiple myeloma 220
Transcriptional features of 1Q in multiple myeloma 219
Quantitative analysis of repetitive elements methylation in B-cell chronic lymphocytic leukemia 215
Relevance of Ras gene mutations in the context of the molecular heterogeneity of multiple myeloma 213
Genome-wide analysis of DNA copy number in multiple myeloma using high-density SNP arrays reveals clustering patterns with distinct transcriptional profiles 211
Transcriptomic analysis in multiple myeloma and primary plasma cell leukemia with t(11;14) reveals different expression patterns with biological implications in venetoclax sensitivity 206
Deregulated microrna expression patterns are associated with high-rish genetic groups in multiple myeloma 204
In Vitro Silencing of lncRNAs Using LNA GapmeRs 204
Mechanisms of immune evasion in multiple myeloma : Open questions and therapeutic opportunities 201
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma 200
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 199
Global hypomethylation of repetitive DNA elements is associated with tumor progression in multiple myeloma 197
Molecular and transcriptional characterization of the novel 17p11-2-p12 chromosome amplification in multiple myeloma 196
Reconstruction of transcriptional regulatory networks in multiple myeloma 185
Investigation of the biological and molecular relevance of NONO protein in multiple myeloma 181
Inference of genomic lesions from single-cell RNA-seq in myeloma improves functional intraclonal and interclonal analysis 181
Quantitative global methylation analysis of DNA repetitive sequences in B-cell chronic lymphocytic leukemia reveals a significant hypomethylation in patients with 17p deletion 180
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in the t(4;14) in multiple myeloma 174
Bioinformatics Pipeline to Analyze lncRNA Arrays 174
Genome-wide analysis of DNA copy number changes in multiple myeloma using high-density SNP arrays 173
Differential repetitive DNA methylation in multiple myeloma molecular subgroups 173
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 172
Transcriptional features of multiple myeloma patients with chromosome 1q gain 172
FUNCTIONAL DISSECTION OF THE SINGLE CELL TRANSCRIPTOMIC LANDSCAPE OF GENOTYPICALLY-IDENTIFIED POLYCLONAL PLASMACELLS IN MULTIPLE MYELOMA MICROENVIRONMENT 170
Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease 166
Multi tyrosine kinase targeting in concomitant downregulation of proliferation/survival pathways dependent on FGF-R3, JAK2 and BCMA in human multiple myeloma cells 163
Exploring the role of NONO in transcriptional regulation of cellular pathways in Multiple Myeloma: insights into its paraspeckle-dependent and independent regulatory mechanisms 161
Transcriptional features of multiple myeloma patients with chromosome 1Q gain 160
The biological relevance of upregulated NONO protein in multiple myeloma through the regulation of cell cycle progression and drug treatment response 154
In silico-identified putative inhibitors of paraspeckle assembly induce cell death by apoptosis in Multiple Myeloma cells and lead to the activation of the cGAS/STING pathway. 154
Molecular analysis of 11q13 breakpoints in multiple myeloma 154
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in the T (4;14) in multiple myeloma 144
Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles 144
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 141
NONO is required for multiple myeloma cell lines growth through stabilisation of lncRNA NEAT1 and paraspeckle integrity 138
Clonal hematopoiesis is clonally unrelated to multiple myeloma and is associated with specific microenvironmental changes 134
Biological and molecular characterization of in silico identified putative inhibitors of paraspeckle assembly with potential anti-multiple myeloma activity 130
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma 130
Characterization of the biological and molecular relevance of nonoprotein in multiple myeloma 130
Combinatorial strategies targeting NEAT1 and AURKA as new potential therapeutic options for multiple myeloma 118
FUNCTIONAL DISSECTION OF THE SINGLE CELL TRANSCRIPTOMIC LANDSCAPE OF GENOTYPICALLY-IDENTIFIED POLYCLONAL PLASMACELLS IN MULTIPLE MYELOMA MICROENVIRONMENT 111
The reconstruction of transcriptional regulatory networks reveals critical genes which have implications for clinical outcome of multiple myeloma 103
Exploring the role of NONO in transcriptional regulation of cellular pathways in Multiple Myeloma: insights into its paraspeckle-dependent and independent regulatory mechanisms 100
null 90
Identification of ceRNA Regulatory Networks Driven by the lncRNA NEAT1 in Multiple Myeloma 2
LNCRNA NEAT1 ORCHESTRATES A CERNA NETWORK GOVERNING CORE PATHWAYS OF PROLIFERATION AND CELLULAR DYNAMICS IN MULTIPLE MYELOMA 1
NONO SHAPES MULTIPLE MYELOMA PROGRESSION THROUGH PARASPECKLE-DEPENDENT AND INDEPENDENT PATHWAYS 1
The biological and molecular relevance of upregulated NONO protein in multiple myeloma. 1
Totale 17.723
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.454
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.454
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.037 102 54 92 70 78 36 94 56 165 74 43 173
2022/20231.062 134 91 88 99 141 195 17 72 125 18 53 29
2023/20242.142 27 54 35 62 214 95 312 284 142 278 291 348
2024/20252.447 315 290 247 258 80 104 127 196 92 172 154 412
2025/20265.606 426 532 647 535 427 280 608 242 494 322 657 436
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 17.723